• Russian Web Tycoon Launches World's Biggest Science Prize

    The Guardian | Yuri Milner, a Russian internet investor who quit his PhD in physics and made $1 billion investing in social networking firms such as Facebook, Twitter and Groupon, has launched a clutch of awards worth $3 million apiece to recognise advances in fundamental physics.

    Jul 31, 2012

  • 23andMe Seeks FDA Approval for Personal DNA Test

    Bloomberg Businessweek | Consumer genetics pioneer 23andMe has taken the first step towards seeking Food and Drug Administration approval of its personalized DNA test.  

    Jul 30, 2012

  • Sharp Dip in US Drug Approvals Forecast

    Pharma Times | The US Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 than it did last year, as the industry faces a number of ongoing operational risks, according to a new report.

    Jul 30, 2012

  • A New Chapter for the Consumer Genetics Conference

    Bio-IT World | Asked what prompted her to launch The Consumer Genetics Conference (CGC) three years ago, together with her friend John Boyce, Meredith Salisbury says simply, “Insanity.” Coming to their senses, the duo have partnered with CHI to produce the 2012 conference, which will be held October 3-5, 2012. 

    Jul 27, 2012

  • Complete Genomics Bundles Ingenuity Variant Analysis software

    Bio-IT World | Complete Genomics announced that it will bundle Ingenuity Systems’ Variant Analysis application with its research whole genome sequencing services.

    Jul 26, 2012

  • John Reynders on the Role of R&D Information at AstraZeneca

    Bio-IT World | In his current role as head of R&D Information at AstraZeneca, John Reynders discusses the breadth of skills among his 400-strong team and the company’s commitment to innovation and long-range strategic planning. 

    Jul 24, 2012

  • Lasker Foundation Begins Search for Next President

    Bio-IT World | The Albert and Mary Lasker Foundation has embarked upon a global search for its next president to lead its operations, succeeding current chief Maria Freire, who is leaving this Fall. 

    Jul 24, 2012

  • 23andMe DNA Mapping Reunites Long-Lost Siblings

    CBS This Morning | Given up for adoption in 1960 at just 10 days, Neil Schwartzman suddenly traced his long-lost biological sister through the online DNA genotyping services of consumer genetics company 23andMe.

    Jul 24, 2012

  • Ion Torrent Named First Entrant in Genomics X Prize Competition

    Bio-IT World | Organizers of the $10-million Archon Genomics X PRIZE competition, presented by Express Scripts, hope that the official entry of Ion Torrent will spur other next-gen sequencing hopefuls to sign up before the contest is held in September 2013.

    Jul 22, 2012

  • New York Genome Center Inks Lease on 6th Avenue

    The Commercial Observer | The New York Genome Center has reportedly completed a deal to lease 150,000 square feet at 101 Avenue of the Americas.

    Jul 20, 2012

  • Human Genes as Company Property Tested by Myriad Patent Case

    Bloomberg Businessweek | Madeleine Ball, a Harvard University geneticist, says entire regions of the human genome are at risk of becoming inaccessible to anyone who can’t afford to pay for patent licenses, stifling the information-sharing that is vital to scientific progress.

    Jul 19, 2012

  • Quantum Tunes Up StorNext For 'Big Data' Files

    Tech Target | Quantum Corp., is updating its StorNext file management and archiving software to manage the velocity, volume and variety of 'Big Data' files in various verticals including life sciences.

    Jul 18, 2012

  • How to Get Along With Bioinformaticians

    The Scientist | Even when bioinformaticians and classically trained biologists appreciate each other’s input, they don’t always understand each other’s work processes.

    Jul 18, 2012

  • Genomatix Maps Future Growth at Bench and Bedside

    Bio-IT World | Genomatix, one of a rapidly growing number of software companies competing in the genome analysis, annotation and interpretation space, believes its traditional expertise in gene regulation and expression provides a distinct edge.

    Jul 17, 2012

  • Life Technologies Buys Navigenics for Genetic Diagnostics

    Bloomberg Businessweek | Life Technologies has purchased closely held personal genomics company Navigenics, bolstering its ability to provide gene diagnostics in a fast-growing market, with an initial focus likely to be on cancer.

    Jul 17, 2012

  • INSIDE THE BOX: Solutions for Data Sharing in Life Sciences

    Bio-IT World | INSIDE THE BOX -- Big data is not a new problem nor is it limited to biological sciences. Luckily, the commercial world has found some innovations in analytics that can teach us some lessons to help solve our own problems.

    Jul 16, 2012

  • Open Access to British Scientific Research in Two Years

    The Guardian | The British government is to unveil controversial plans to make publicly funded scientific research immediately available for anyone to read for free by 2014, in the most radical shakeup of academic publishing since the invention of the internet. 

    Jul 16, 2012

  • Allan Snavely, Architect of Gordon Supercomputer, Dies

    HPC Wire | Allan Snavely, a widely recognized expert in high-performance computing whose innovative thinking led to the development of the Gordon supercomputer at the San Diego Supercomputer Center at UC San Diego, died of an apparent heart attack over the weekend.

    Jul 16, 2012

  • Better Medicine Brought to You by Big Data

    GigaOM | Whether it’s Hadoop, machine learning, natural-language processing or some other technique, folks in the worlds of medicine and hospital administration understand that new types of data analysis are the key to helping them take their fields to the next level.

    Jul 16, 2012

  • The Skeptical Outsider: How to Rescue the Life Sciences from Technological Torpor

    Bio-IT World | The Skeptical Outsider | Can a new generation of computational biologists cross-trained in the engineering disciplines, rescue the pharmaceutical industry, long overdue for change, asks Bill Frezza in his July 'Skeptical Outsider' column. 

    Jul 13, 2012